T-Therapeutics
Signal active
Organization
Contact Information
Overview
T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration.
.
About
Industries
Biotechnology, Health Care, Medical
Founded
2022
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
T-Therapeutics headquartered in Europe, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $715.5M in funding across 12 round(s). With a team of 11-50 employees, T-Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - T-Therapeutics, raised $59.6M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
6
Lead Investors
0
Total Funding Amount
$59.6M
Details
1
T-Therapeutics has raised a total of $59.6M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 59.6M |
Investors
T-Therapeutics is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| T-Therapeutics | - | FUNDING ROUND - T-Therapeutics | 59.6M |
| Digitalis Ventures | - | FUNDING ROUND - Digitalis Ventures | 59.6M |
| T-Therapeutics | - | FUNDING ROUND - T-Therapeutics | 59.6M |
| University of Cambridge Enterprise | - | FUNDING ROUND - University of Cambridge Enterprise | 59.6M |
Recent Activity
There is no recent news or activity for this profile.